371 related articles for article (PubMed ID: 22339849)
21. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
22. X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis.
Wu H; Xu C; Chen G; Wang J
J Gastroenterol Hepatol; 2014 May; 29(5):926-33. PubMed ID: 24224851
[TBL] [Abstract][Full Text] [Related]
23. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
[TBL] [Abstract][Full Text] [Related]
24. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
[TBL] [Abstract][Full Text] [Related]
25. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
[TBL] [Abstract][Full Text] [Related]
26. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX
PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310
[TBL] [Abstract][Full Text] [Related]
27. XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population.
Wang Z; Xu B; Lin D; Tan W; Leaw S; Hong X; Hu X
Lung Cancer; 2008 Oct; 62(1):99-104. PubMed ID: 18400332
[TBL] [Abstract][Full Text] [Related]
28. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma.
Yin Z; Zhou B; He Q; Li M; Guan P; Li X; Cui Z; Xue X; Su M; Ma R; Bai W; Xia S; Jiang Y; Xu S; Lv Y; Li X
BMC Cancer; 2009 Dec; 9():439. PubMed ID: 20003463
[TBL] [Abstract][Full Text] [Related]
29. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis.
Wu J; Liu J; Zhou Y; Ying J; Zou H; Guo S; Wang L; Zhao N; Hu J; Lu D; Jin L; Li Q; Wang JC
Clin Cancer Res; 2012 Jul; 18(14):3972-81. PubMed ID: 22705987
[TBL] [Abstract][Full Text] [Related]
31. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
32. Association between Polymorphisms of X-Ray Repair Cross Complementing Group 1 Gene and Pancreatic Cancer Risk: a Systematic Review with Meta-Analysis.
Chen J; Wang H; Li Z
Pathol Oncol Res; 2019 Jul; 25(3):897-904. PubMed ID: 29285737
[TBL] [Abstract][Full Text] [Related]
33. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln), and the risk of age-related cataract: a meta-analysis.
Liu XC; Liu XF; Hu ZD; Li ZH
Curr Eye Res; 2015 Jul; 40(7):676-82. PubMed ID: 25285569
[TBL] [Abstract][Full Text] [Related]
35. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
[TBL] [Abstract][Full Text] [Related]
36. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
37. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
[TBL] [Abstract][Full Text] [Related]
38. A promoter polymorphism (-77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking.
Hu Z; Ma H; Lu D; Zhou J; Chen Y; Xu L; Zhu J; Huo X; Qian J; Wei Q; Shen H
Pharmacogenet Genomics; 2005 Jul; 15(7):457-63. PubMed ID: 15970793
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the influence of chronic low-dose radiation on DNA repair gene polymorphisms [
Saini D; Sudheer KR; Kumar PRV; Soren DC; Jain V; Koya PKM; Jaikrishan G; Das B
Int J Radiat Biol; 2020 Jun; 96(6):734-739. PubMed ID: 32149571
[No Abstract] [Full Text] [Related]
40. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
